Skinvisible, Inc.
SKVI
$0.58
$0.047.41%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Cost of Revenue | -- | -- | -- | -- | 0.00 |
| Gross Profit | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| SG&A Expenses | 527.20K | 516.80K | 486.90K | 491.70K | 472.90K |
| Depreciation & Amortization | 20.10K | 18.70K | 18.70K | 18.60K | 18.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 547.40K | 535.50K | 505.60K | 510.30K | 491.50K |
| Operating Income | -527.40K | -515.50K | -485.60K | -490.30K | -471.50K |
| Income Before Tax | -1.18M | -1.19M | -1.16M | -2.38M | -2.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.18 | -1.19 | -1.16 | -2.38 | -2.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.18M | -1.19M | -1.16M | -2.38M | -2.48M |
| EBIT | -527.40K | -515.50K | -485.60K | -490.30K | -471.50K |
| EBITDA | -507.20K | -496.80K | -466.90K | -471.70K | -452.90K |
| EPS Basic | -0.26 | -0.26 | -0.26 | -0.52 | -0.55 |
| Normalized Basic EPS | -0.16 | -0.16 | -0.16 | -0.33 | -0.34 |
| EPS Diluted | -0.26 | -0.26 | -0.26 | -0.52 | -0.55 |
| Normalized Diluted EPS | -0.16 | -0.16 | -0.16 | -0.33 | -0.34 |
| Average Basic Shares Outstanding | 18.16M | 18.16M | 18.16M | 18.16M | 18.16M |
| Average Diluted Shares Outstanding | 18.26M | 18.26M | 18.16M | 18.16M | 18.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
